SonoThera
Develops ultrasound-mediated nonviral genetic medicines
$125MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops ultrasound-mediated nonviral genetic medicines
Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing
Develops next-generation cell therapies for oncology and immunology
Develops inhaled therapies for severe respiratory diseases
Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo...